Role of Orexin-A in Hypertension and Obesity

被引:38
|
作者
Roberta, Imperatore [1 ,2 ]
Letizia, Palomba [3 ]
Luigia, Cristino [1 ]
机构
[1] CNR, Inst Biomol Chem, Endocannabinoid Res Grp, Viale Campi Flegrei, I-80078 Pozzuoli, Italy
[2] Univ Sannio, Dept Sci & Technol, Benevento, Italy
[3] Univ Urbino Carlo Bo, Dept Biomol Sci, Urbino, Italy
关键词
Orexin; Obesity; Hypertension; Catecholamine; Epinephrine; Norepinephrine; ROSTRAL VENTROLATERAL MEDULLA; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; SYMPATHETIC PREGANGLIONIC NEURONS; DEPENDENT SIGNALING CASCADE; MESSENGER-RIBONUCLEIC-ACID; RENIN-ANGIOTENSIN SYSTEM; PITUITARY-ADRENAL AXIS; CENTRAL-NERVOUS-SYSTEM; BLOOD-PRESSURE; RAT-BRAIN;
D O I
10.1007/s11906-017-0729-y
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Purpose of Review Hypertension is one of the most challenging health problems inducing cerebrovascular disease and high percentage of death when associated with diabetes, dyslipidemias, and obesity. Orexin/hypocretin is a peptide expressed by a small number of neurons of the dorsolateral hypothalamus, a brain feeding and autonomic "fight-or-flight" regulatory center. According to this function, orexin has been demonstrated to evoke cardiovascular responses, heart rate, hypertension, hyperarousal, hyperphagia, and obesity. The focus of this review is to provide an overview about the mechanism through which orexin regulates food intake and cardiovascular responses and its role in the pathogenesis of obesity and hypertension which could be of great interest to establish possible new therapies. Recent Findings In normal rats and mice, central administration of orexin increases food intake, blood pressure, and sympathetic nerve activity and these effects are blocked by selective orexin receptor antagonist SB-334867 or almorexant. Moreover, upregulation of orexin signaling, in combination with elevation of epinephrine and norepinephrine circulating levels, occurs in rats exposed to chronic stress, in models of spontaneous hypertension SHR and BPH/2J Schlager mice) and in obese mice (ob/ob or mice fed with high fat diet). Therefore, hyperactivity of orexinergic neurons could be a factor in the development of obesity and essential hypertension. Summary Because of their widespread projections to the brain regions involved in appetite and cardiovascular responses, as far down as sympathetic preganglionic neurons in the spinal cord, orexin evokes sympathetically mediated cardiovascular responses. Lasting upregulation of orexin signaling can lead to hyperphagia, obesity, and hypertensive state. Dual orexin receptor antagonists (DORAs) and selective orexin receptor antagonists (SORAs) have antihypertensive effects that could be of clinical use for regulation of food intake and hypertension, supporting the role of orexinergic neurons as critical checkpoint in the neurogenic control of metabolic and cardiovascular functions.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] The Subthalamic Neurons are Activated by Both Orexin-A and Orexin-B
    Sheng, Qing
    Xue, Yan
    Chen, Ying Wang An-Qi
    Liu, Cui
    Liu, Yun-Hai
    Chu, Hong-Yan
    Chen, Lei
    NEUROSCIENCE, 2018, 369 : 97 - 108
  • [22] Implicating the potential role of orexin in hypertension
    Monika Rani
    Raghuvansh Kumar
    Pawan Krishan
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2017, 390 : 667 - 676
  • [23] OREXIN-A, A NOVEL LOCAL REGULATOR IN THE KIDNEY
    Takahashi, Kazuhiro
    Arihara, Zenei
    Totsune, Kazuhito
    Sone, Masahiko
    Kikuchi, Kumi
    Murakami, Osamu
    NEPHROLOGY, 2005, 10 : A270 - A270
  • [24] Respiratory and cardiovascular actions of orexin-A in mice
    Zhang, W
    Fukuda, Y
    Kuwaki, T
    NEUROSCIENCE LETTERS, 2005, 385 (02) : 131 - 136
  • [25] Orexin-A expression in human peripheral tissues
    Nakabayashi, M
    Suzuki, T
    Takahashi, K
    Totsune, K
    Muramatsu, Y
    Kaneko, C
    Date, F
    Takeyama, J
    Darnel, AD
    Moriya, T
    Sasano, H
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2003, 205 (1-2) : 43 - 50
  • [26] Plasma orexin-A is lower in patients with narcolepsy
    Higuchi, S
    Usui, A
    Murasaki, M
    Matsushita, S
    Nishioka, N
    Yoshino, A
    Matsui, T
    Muraoka, H
    Ishizuka, Y
    Kanba, S
    Sakurai, T
    NEUROSCIENCE LETTERS, 2002, 318 (02) : 61 - 64
  • [27] Effects of orexin-A on propofol anesthesia in rats
    Shirasaka, Tetsuro
    Yonaha, Tetsu
    Onizuka, Shin
    Tsuneyoshi, Isao
    JOURNAL OF ANESTHESIA, 2011, 25 (01) : 65 - 71
  • [28] Orexin-A System Neuromodulation by Intrathecal Baclofen
    Margetis, Konstantinos
    Markianos, Manolis
    Gatzonis, Stylianos
    Kalamatianos, Theodosis
    Sakas, Damianos
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2014, 34 (04) : 535 - 537
  • [29] Distribution of orexin-A and orexin-B (hypocretins) in the rat spinal cord
    Date, Y
    Mondal, MS
    Matsukura, S
    Nakazato, M
    NEUROSCIENCE LETTERS, 2000, 288 (02) : 87 - 90
  • [30] SAR of the novel neuropeptides orexin-A and B
    Jarosinski, MA
    Dodson, WS
    Harding, BJ
    Zamborelli, TJ
    Lenz, DM
    Cooke, K
    Yan, H
    Baumgartner, J
    Karbon, EW
    PEPTIDES FOR THE NEW MILLENNIUM, 2000, : 668 - 670